Cart
Oops, your cart is still empty
Looks like you haven’t added anything yet. Start exploring our products and find what you need.
Peptides in Inflammation Research: A Complete Overview
These materials are research-grade reference compounds sold for laboratory research use only. They are not for human or veterinary use.
Inflammation is one of the most active areas of peptide research, and several peptides from different families recur in it. They are studied in cell-based inflammation assays and animal models for their effects on inflammatory signaling pathways such as NF-kB, and on immune-cell behavior. This overview maps which peptides appear in that literature, explains the recurring mechanisms, and links to each compound’s reference page. It describes research findings and does not describe treatments for people.
At a Glance
- KPV, LL-37, and BPC-157 are among the peptides most studied in inflammation research.
- Reported pathways include NF-kB signaling and host-defense mechanisms in models.
- The peptides come from different families but overlap in this research context.
- Findings are model observations and are not statements about treating inflammation in people.
- All are research chemicals for laboratory use only.
What This Research Area Covers?
Inflammation research with peptides examines effects on inflammatory signaling pathways, immune-cell function, and tissue responses in defined models. Because inflammation is a shared biological process, peptides from repair, host-defense, and melanocortin-derived families all appear here, which is why the area is best approached as a cross-family research theme rather than a single class.
Peptides Studied in This Area
| Compound | Family / origin | Inflammation-research association |
|---|---|---|
| KPV | Melanocortin-derived tripeptide | NF-κB signaling in intestinal-inflammation models |
| LL-37 | Human cathelicidin | Host-defense and immunomodulatory activity |
| BPC-157 | Gastric pentadecapeptide | Tissue-protective effects in gastrointestinal models |
Recurring Mechanisms in the Literature
NF-kB modulation
NF-kB is a central transcription-factor pathway in inflammation. KPV, a melanocortin-derived tripeptide, is studied for effects on this pathway in intestinal-inflammation models, where its uptake and anti-inflammatory signaling have been reported (Dalmasso et al., 2008).
Host-defense and immunomodulation
LL-37, the human cathelicidin, is studied as a host-defense peptide with immunomodulatory roles, bridging antimicrobial and inflammation research (Vandamme et al., 2012).
Tissue protection
BPC-157 appears in gastrointestinal and tissue-repair models with reported cytoprotective effects that intersect with inflammatory processes (Seiwerth et al., 2021).
How the Area Is Studied?
Research uses cell-based inflammation assays and animal models, with endpoints such as cytokine signaling, NF-kB activity, immune-cell recruitment, and tissue-level responses. Because the peptides come from different families, the specific assays vary, but the shared thread is inflammatory-pathway biology.
Chemical Identity and Verification
Each compound is verified by HPLC for purity and mass spectrometry for identity, documented on the per-lot Certificate of Analysis. Identity data differ by compound and should be read from each COA.
Handling and Documentation
Store sealed material cold, shield it from light, and avoid repeated freeze-thaw. Lot-specific stability is documented on the COA; current lot reports are on the Lab Reports page.
Research Limitations and Open Questions
All of this work is in cell and animal models, and inflammatory-pathway findings in those systems do not establish outcomes in people. Because the peptides come from different families, cross-compound generalizations should be avoided; each is best interpreted within its own primary literature.
Frequently Asked Questions
Which peptides are studied in inflammation research?
KPV, LL-37, and BPC-157 are common examples, each from a different family.
What pathways appear in the literature?
NF-kB signaling and host-defense mechanisms are recurring themes in models.
What is KPV?
A melanocortin-derived tripeptide studied for anti-inflammatory signaling, including effects on NF-kB in intestinal models.
Are these human treatment results?
No. They are research-model observations, not statements about treating inflammation in people.
Why group peptides from different families?
Because inflammation is a shared biological process that these peptides intersect with in research, even though they belong to different classes.
How are the compounds verified?
By HPLC and mass spectrometry, documented on the per-lot Certificate of Analysis.
How should they be stored?
Sealed, cold, shielded from light, avoiding repeated freeze-thaw; lot-specific stability is on the COA.
Related Reading
References
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008. PMID 18061177.
- Vandamme D, et al. A comprehensive summary of LL-37. Cell Immunol. 2012. PMID 23246832.
- Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021. PMID 34267654.
Research-use notice: The peptides described here are research chemicals sold for laboratory research use only. They are not for human or veterinary use. Every finding is reported in the specific research context of the cited study.
